Library
Repair & Recovery

TB-500

Thymosin Beta-4 (synthetic fragment)

The actin-sequestering peptide behind cellular motility and cardiac repair.

Half-life

~ several hours (fragment); full Tβ4 is endogenous

Mol. weight

~ 4.9 kDa (full Tβ4); fragment varies

Sequence

Fragment of thymosin beta-4 (actin-binding domain)

Discussions

1 threads

Overview

TB-500 is a synthetic fragment of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide that is the most abundant G-actin (monomeric actin) binding protein in mammalian cells. Tβ4 is implicated in cell migration, proliferation, angiogenesis, inhibition of apoptosis, and inflammation control — and has shown remarkable cardiac repair potential in developmental biology research by reactivating embryonic repair programs in adult hearts.

Mechanism of action

Tβ4's primary action is sequestering G-actin, maintaining a pool of monomeric actin that cells can rapidly polymerize into filaments for migration — essential for wound healing and tissue remodeling. In the heart, Tβ4 activates integrin-linked kinase (ILK) and downstream Akt, promoting cardiac cell survival and migration. It also activates capsulin-positive progenitor cells and triggers organ-wide epicardial thickening, effectively reminding adult organs of their embryonic state to initiate regeneration. TB-500 is the short synthetic fragment (commonly the N-terminal actin-binding domain, ~17 amino acids) used in research to deliver the actin-sequestering and tissue-repair signaling of the full-length molecule.

Researched benefits

  • Promotes cell migration and tissue remodeling via actin sequestration
  • Stimulates angiogenesis and inhibits apoptosis
  • Demonstrated cardiac cell survival and repair in animal models (ILK/Akt pathway)
  • Activates progenitor cells and embryonic-like repair programs in the heart
  • Anti-inflammatory and wound-healing activity in preclinical studies

Considerations

  • Clinical evidence in humans is limited; most data is preclinical
  • TB-500 is a fragment of full-length thymosin beta-4 — distinct from the native molecule
  • Not FDA-approved; research use only
  • Should be researched under professional guidance

Key Academic Literature & Studies

Search more in PubMed

Peer-reviewed citations and clinical trials evaluating TB-500 in scientific literature.

Articles & logs